Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background and Purpose: EEG studies show that 5‐HT is involved in regulation of sleep–wake state and modulates cortical oscillations. Vortioxetine is a 5‐HT 3, 5‐HT 7, and 5‐HT 1Dreceptor antagonist, 5‐HT 1Bpartial agonist, 5‐HT 1Aagonist, and 5‐HT transporter inhibitor. Preclinical (animal) and clinical studies with vortioxetine show positive impact on cognitive metrics involving cortical function. Here we assess vortioxetine's effect on cortical neuronal oscillations in actively awake rats. Experimental Approach: Telemetric EEG recordings were obtained with the following treatments (mg·kg−1, s.c.): vehicle, vortioxetine (0.1, 1.0, 3.0, 10), 5‐HT 1Aagonist flesinoxan (2.5), 5‐HT 3antagonist ondansetron (0.30), 5‐HT 7antagonist SB‐269970‐A(10), escitalopram (2.0), duloxetine (10) and vortioxetine plus flesinoxan. Target occupancies were determined by ex vivo autoradiography. Key Results: Vortioxetine dose‐dependently increased wakefulness. Flesinoxan, duloxetine, ondansetron, but not escitalopram or SB‐269970‐A increased wakefulness. Quantitative spectral analyses showed vortioxetine alone and with flesinoxan increased θ (4–8 Hz), α (8–12 Hz) and γ (30–50 Hz) power. Duloxetine had no effect on θ and γ, but decreased α power, while escitalopram produced no changes. Ondansetron and SB‐269970 (≈31–35% occupancy) increased θ power. Flesinoxan (≈41% occupancy) increased θ and γ power. Conclusions and Implications: Vortioxetine increased wakefulness and increased frontal cortical activity, most likely because of its 5‐HT 7and 5‐HT 3antagonism and 5‐HT 1Aagonism. Vortioxetine differs from escitalopram and duloxetine by increasing cortical θ, α and γ oscillations. These preclinical findings suggest a role of vortioxetine in modulating cortical circuits known to be recruited during cognitive behaviours and warrant further investigation as to their clinical impact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Dynamic predictions: Oscillations and synchrony in top–down processing
Engel, A. K., Fries, P., & Singer, W. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094565 · Cited by 3,454 · cited 1×
“Gamma power is a near-ubiquitous feature of ongoing cortical activity and is involved in multiple aspects of cognitive computation, sensory representation and short-term memory (Engel et al., 2001; Kaiser and Lutzenberger, 2005; Kaiser et al., 2008; Ainsworth et al., 2011).”
Theta oscillations in the hippocampus
Buzsáki, G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00586-x · Cited by 3,332
Alpha-band oscillations, attention, and controlled access to stored information
Klimesch, W. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2012.10.007 · Cited by 3,310
Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
The role of phase synchronization in memory processes
Fell, J., & Axmacher, N. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2979 · Cited by 1,620
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C., & Wainwright, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00873.x · Cited by 1,592
Control of sleep and wakefulness
Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E., & McCarley, R. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00032.2011 · Cited by 1,477
Memory processes, brain oscillations and EEG synchronization
Klimesch, W. (1996) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(96)00057-8 · Cited by 923 · cited 2×
“For example, preclinical and clinical data suggest that theta oscillations tend to increase during memory tasks, especially during encoding (Klimesch, 1996; 1999; Başar et al., 2000).”
Gating of human theta oscillations by a working memory task
Raghavachari, S., Kahana, M. J., Rizzuto, D. S., Caplan, J. B., Kirschen, M. P., Bourgeois, B., Madsen, J. R., & Lisman, J. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03175.2001 · Cited by 792 · cited 2×
“Moreover, hippocampal theta power is linked to memory, particularly spatial memory in rats, while in humans, an increase in theta correlated with improved performance on working memory tasks (Caplan et al., 2001; Raghavachari et al., 2001; 2006).”
The functional significance of delta oscillations in cognitive processing
Harmony, T. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00083 · Cited by 788
(1997) · Neuroscience · doi:10.1016/s0306-4522(97)00239-x · Cited by 707
Serotonin control of sleep-wake behavior
Monti, J. M. (2011) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2010.11.003 · Cited by 614
Bang-Andersen, B., Ruhland, T., Jørgensen, M., Smith, G., Frederiksen, K., Jensen, K. G., Zhong, H., Nielsen, S. M., Hogg, S., Mørk, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101459g · Cited by 606 · cited 4×
“The previously published in vitro binding affinities (Bang-Andersen et al., 2011; Mørk et al., 2012) are also shown in order to highlight the species differences for some of the targets.”
InfluentialMeyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.826 · Cited by 517 · cited 6×
“AHP, after hyper-polarization SB-269970-A; BBB, blood–brain barrier; DSI, Data Sciences International; LMA, locomotor activity; qEEG, quantitative EEG; REM, rapid eye movement sleep; ROI, region of interest; SERT, 5-HT (serotonin) transporter; SNRI, 5-HT (serotonin) / noradrenaline reuptake inhibitor; SSRI, 5-HT (sero…”
InfluentialNeurocognitive Mechanisms in Depression: Implications for Treatment
Clark, L., Chamberlain, S. R., & Sahakian, B. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125618 · Cited by 446
Katona, C., Hansen, T., & Olsen, C. K. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283542457 · Cited by 445 · cited 2×
“…Westrich et al., 2012; Bétry et al., 2013; Pehrson et al., 2013), and its antidepressant efficacy has been demonstrated in clinical studies (Adell, 2010; Alvarez et al., 2012; Baldwin et al., 2012a,b,c; Boulenger et al., 2012; Henigsberg et al., 2012; Katona et al., 2012; McIntyre et al., 2013).”
Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review
Hasselbalch, B. J., Knorr, U., & Kessing, L. V. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.011 · Cited by 406 · cited 1×
“Furthermore, deficits in cognitive function may persist beyond clinical recovery from the depressive symptoms (Bhardwaj et al., 2010; Hasselbalch et al., 2011).”
Mørk, A., Pehrson, A., Brennum, L. T., Nielsen, S. M., Zhong, H., Lassen, A. B., Miller, S., Westrich, L., Boyle, N. J., Sánchez, C., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189068 · Cited by 271 · cited 3×
“The previously published in vitro binding affinities (Bang-Andersen et al., 2011; Mørk et al., 2012) are also shown in order to highlight the species differences for some of the targets.”
Self-citation5-HT1A receptor-regulated signal transduction pathways in brain
Polter, A. M., & Li, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.019 · Cited by 225
Alvarez, E., Perez, V., Dragheim, M., Loft, H., & Artigas, F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001027 · Cited by 225 · cited 1×
“…Westrich et al., 2012; Bétry et al., 2013; Pehrson et al., 2013), and its antidepressant efficacy has been demonstrated in clinical studies (Adell, 2010; Alvarez et al., 2012; Baldwin et al., 2012a,b,c; Boulenger et al., 2012; Henigsberg et al., 2012; Katona et al., 2012; McIntyre et al., 2013).”
Circadian and wakefulness-sleep modulation of cognition in humans
Wright, K. P., Lowry, C. A., & LeBourgeois, M. K. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00050 · Cited by 209 · cited 1×
“…is in close interaction with other neurotransmitter systems, including ACh, glutamate, dopamine, noradrenaline, histamine and orexin (hypocretin), and is involved in the regulation of circadian and cognitive processes (Sebban et al., 1999; Monti, 2011; Miyamoto et al., 2012; Wright et al., 2012).”
McNaughton, N., Kocsis, B., & Hajós, M. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee82e3 · Cited by 187 · cited 1×
“Modulation by 5-HT is known to play an important role in the generation and regulation of theta power (Stäubli and Xu, 1995; Vertes and Kocsis, 1997; Bland et al., 1999; Dragoi et al., 1999; Buzsaki, 2002; Hajós et al., 2003b; McNaughton et al., 2007; Sörman et al., 2011).”
Translating Glutamate: From Pathophysiology to Treatment
Javitt, D. C., Schoepp, D., Kalivas, P. W., Volkow, N. D., Zarate, C., Merchant, K., Bear, M. F., Umbricht, D., Hajos, M., Potter, W. Z., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002804 · Cited by 168 · cited 1×
“Importantly, there is increasing evidence that EEG methodologies have high translational value from rodent to human (Ruigt, 2002; Drinkenburg and Ahnaou, 2004; Paterson et al., 2007; Javitt et al., 2008; 2011; Day et al., 2011; Leiser et al., 2011; Wilson et al., 2013).”
Pehrson, A. L., Cremers, T., Bétry, C., van der Hart, M. G. C., Jørgensen, L., Madsen, M., Haddjeri, N., Ebert, B., & Sanchez, C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.006 · Cited by 155 · cited 8×
“…has been shown to enhance extracellular levels of ACh, dopamine,noradrenaline, 5-HT and histamine in the prefrontal cortex (Mørk et al., 2013; Pehrson et al., 2013), it appeared reasonable to hypothesize that vortioxetine can increase frontal cortical oscillations in a manner that may act…”
InfluentialSelf-citationHenigsberg, N., Mahableshwarkar, A. R., Jacobsen, P., Chen, Y., & Thase, M. E. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07470 · Cited by 150
du Jardin, K. G., Jensen, J. B., Sanchez, C., & Pehrson, A. L. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.07.001 · Cited by 133
Self-citationBoulenger, J.-P., Loft, H., & Florea, I. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112441866 · Cited by 127 · cited 1×
“…Westrich et al., 2012; Bétry et al., 2013; Pehrson et al., 2013), and its antidepressant efficacy has been demonstrated in clinical studies (Adell, 2010; Alvarez et al., 2012; Baldwin et al., 2012a,b,c; Boulenger et al., 2012; Henigsberg et al., 2012; Katona et al., 2012; McIntyre et al., 2013).”
A dose-finding study of duloxetine based on serotonin transporter occupancy
Takano, A., Suzuki, K., Kosaka, J., Ota, M., Nozaki, S., Ikoma, Y., Tanada, S., & Suhara, T. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0304-0 · Cited by 110
Effects of 5-HT on memory and the hippocampus: model and data.
Meeter, M., Talamini, L., Schmitt, J. A. J., & Riedel, W. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300869 · Cited by 68 · cited 2×
“…brain regions such as the dorsal raphe, entorhinal cortex, hippocampus and central amygdala (Chalmers and Watson, 1991; Polter and Li, 2010), has been linked to memoryenhancing effects (Meneses and Hong, 1999; Meeter et al., 2006; Newman-Tancredi et al., 2009; Depoortere et al., 2010).”
Areberg, J., Luntang‐Jensen, M., Søgaard, B., & Nilausen, D. Ø. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00810.x · Cited by 68
Cited by
Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.07.001 · Cited by 547
Vortioxetine: a novel antidepressant for the treatment of major depressive disorder
Gonda, X., Sharma, S. R., & Tarazi, F. I. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1546691 · Cited by 123
Dale, E., Zhang, H., Leiser, S. C., Xiao, Y., Lu, D., Yang, C. R., Plath, N., & Sanchez, C. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114543719 · Cited by 93
Self-citationDe Diego-Adeliño, J., Crespo, J. M., Mora, F., Neyra, A., Iborra, P., Gutiérrez-Rojas, L., & Salonia, S. F. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2019705 · Cited by 67
Bétry, C., Etiévant, A., Pehrson, A., Sánchez, C., & Haddjeri, N. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.12.002 · Cited by 59
“A similar enhancing effect on cell proliferation was obtained with the vortioxetine/SR57227 combination and such an effect occurred with a low (30%) SERT occupancy (Table 1) but likely close to full occupancy of 5-HT3 receptors (Leiser et al., 2014).”
InfluentialSelf-citation
Metadata
- Authors
- Leiser, S. C., Pehrson, A. L., Robichaud, P. J., & Sanchez, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2014-08-28
- Volume
- 171
- Issue
- 18
- Pages
- 4255-4272
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1546718520
- Cited by
- 63
- References
- 32
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.